Clinical Trial Update: Efficacy and Safety of Therapy With IgM-enriched Immunoglobulin With a Personalized Dose vs Standard Dose in Patients With Septic Shock. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating IgM-enriched immunoglobulin with personalized dosing versus standard dosing in septic shock; efficacy and safety outcomes are under inv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoglobulinemia
• Sepsis
• Septic Shock

Drugs mentioned

• IgM-enriched immunoglobulin (IgM-enriched immunoglobulin)

Snippet

Sponsor: Massimo Girardis | Conditions: Shock, Septic, Sepsis | Phase 3 | Status: UNKNOWN